TIMOTHY LEARY’S DEAD? –
Jan. 13, 2026 – In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally occurring hallucinogen better known as magic mushrooms, or “shrooms,” has decisively pulled ahead of the pack … “Between research results and policy changes, it’s a watershed moment for psychedelic health care, and psilocybin is the star.” State lawmakers, however, are not waiting for regulators in the nation’s capital.
Last year, New Mexico joined Colorado and Oregon in offering legal psilocybin therapy to adults. Lawmakers in a dozen states, including North Carolina, Maryland, Georgia and California, are considering easing restrictions on the drug using public funds to research the potential benefits of psilocybin therapy.
But the rollout of Oregon’s psilocybin program over the past two years has not gone as well as anticipated, highlighting the challenges that states and companies will most likely face as psychedelic medicine becomes more widely available. Costly licensing and staffing requirements have made the price of sessions unaffordable for many, leading to the closings of a third of Oregon’s 36 licensed service centers.
